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Fasciola gigantica produces excretory-secretory products (ESPs) with immune-
modulating effects to promote its own survival. In this study, we performed RNA-seq to
gain a comprehensive global understanding of changes in the expression of mRNAs,
miRNAs, lncRNAs, and circRNAs in goat peripheral blood mononuclear cells (PBMCs)
treated with F. gigantica ESPs. A total of 1,544 differently expressed mRNAs
(790 upregulated and 754 downregulated genes), 30 differently expressed miRNAs
(24 upregulated and 6 downregulated genes), 136 differently expressed circRNAs (83
upregulated and 53 downregulated genes), and 1,194 differently expressed lncRNAs
(215 upregulated and 979 downregulated genes) were identified. Gene Ontology (GO)
and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses revealed
that F. gigantica ESPs altered the expression of genes associated with the host immune
response, receptor signaling, disease and metabolism. Results from RNA-seq were
validated by qRT-PCR. These findings provide an important resource for futureorg April 2021 | Volume 12 | Article 6537551
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modulating effects of F. gigantica ESPs.Keywords: Fasciola gigantica, peripheral blood mononuclear cells, RNA-seq, excretory-secretory products, long
noncoding RNAINTRODUCTION
Fasciolosis, caused by Fasciola gigantica and F. hepatica, is a
significant parasitic disease, causing huge economic losses to
livestock and serious adverse impact on public health (1–3).
Fasciolosis is prevalent in developing countries, particularly in
Asia, Africa, Latin America, and the Caribbean (2, 4, 5). The
annual global economic losses to livestock production caused by
liver fluke infection exceed $3 billion (6). Despite the significant
impact of fasciolosis, our knowledge of host defense mechanisms
against F. gigantica infection remains limited. Exploring the
molecular mechanisms of interaction between the host and
liver flukes would enhance our understanding of the host
immune response and assist in identifying potential targets for
the development of therapeutic interventions against fasciolosis.
Liver flukes employ a raft of strategies to subvert the host’s
immune response, including the secretion of excretory-secretory
products (ESPs) to modulate the host’s immune responses, to
facilitate their own survival and to establish long-term infection (7,
8). In a previous study, by using co-immunoprecipitation coupled
with tandem mass spectrometry, we identified 14, 16, 9, and 9
proteins in F. hepatica ESPs (FhESPs) that can bind to cytokines
IL2, IL17, IFN-g, and goat peripheral blood mononuclear cells
(PBMCs) (9). In addition, a proteomic analysis of FgESPs
interacting with buffalo serum at different infection periods (42,
70, and 98 dpi) identified 18 proteins after F. gigantica infection,
including 13 cathepsin proteins, 4 glutathione S-transferase
proteins, and 1 calcium-binding protein (10).
To identify the role of these proteins in the long-term survival
of F. gigantica, we cloned and expressed the recombinant F.
gigantica cathepsin B (rFgCatB), 14-3-3 epsilon (rFg14-3-3e),
Ras-related Rab10 (rFgRab10) and thioredoxin peroxidase
(rFgTpx) proteins, and characterized their effects on various
functions of the goat PBMCs (11–14). In the related liver fluke
F. hepatica, tegumental antigen affects the maturation and antigen
presentation to host dendritic cells (DCs) (15). Furthermore, F.
hepatica fatty acid-binding protein inhibits the activation of Toll-
like Receptor (TLR) 4 and suppresses the expression of
inflammatory cytokines induced by lipopolysaccharide (LPS) (16).
Although ESPs play a significant role in supporting liver
flukes’ evasion of the host immune response, the molecular
mechanisms that are mediated by ESPs remain poorly defined.
To reveal new aspects of the immuno-modulatory effects of F.
gigantica ESPs, we investigated the expression profiles of
messenger RNAs (mRNAs), microRNAs (miRNAs), circular
RNAs (circRNAs), and long non-coding RNA (lncRNAs) in
goat PBMCs following incubation with ESPs of F. gigantica. The
results showed that ESPs can regulate the proliferation, immune
response, and metabolism of treated PBMCs. Our data provideorg 2new information for further in-depth analysis of the role of ESPs
in the immune-evasive strategy of F. gigantica.MATERIALS AND METHODS
Source and Culture Conditions
of the PBMCs
Goat PBMCs were isolated as previously described (11). Briefly,
healthy goat venous blood samples mixed with ethylene diamine
tetraacetic acid (EDTA) were collected into vacutainer tubes.
Goat PBMCs were isolated using a commercial kit (TBD,
Tianjin, China) according to the manufacturer’s instructions.
The isolated PBMCs were cultured in RPMI 1640 medium
containing 10% fetal bovine serum (FBS) and 1% penicillin-
streptomycin (Gibco, California, USA) and were incubated in a
humidified atmosphere of 5% CO2 at 37°C for 4 h.
Preparation of ESPs
ESPs of F. gigantica were prepared according to a previously
described method (15, 17–19). Briefly, adult liver flukes of F.
gigantica were obtained from the bile ducts of slaughtered
buffaloes naturally infected by F. gigantica and washed three
times with phosphate-buffered saline (PBS) at 37°C. The washed
adult flukes were then transferred to PBSG buffer (PBS
containing glucose, supplemented with 10,000 UI/ml penicillin
G, 10 mg/ml streptomycin sulfate, and 25 mg/ml amphotericin B)
and incubated in plastic petri dishes (1 worm/2 mL) for 2 h at 37°C.
The supernatant was collected three times (i.e., every 2 h over a 6-h
period). After incubation, the supernatant was collected and
centrifuged at 10,000g for 30 min at 4°C, then filter-sterilized with
a 20-mm nylon filter. After filter-sterilization, ESPs were
concentrated using Amicon® Ultra-15 centrifugal filter devices
(30 K), and the concentration of ESPs was measured by the
Bicinchoninic Acid Protein Assay (BCA-1, Sigma-Aldrich, Corp.,
St. Louis, MO, USA) and stored at −80°C until analysis.
RNA Extraction and RNA-seq
PBMCs (1 × 106) were incubated with 80 µg of F. gigantica ESPs
or an equal volume of PBS (controls) at 37°C with 5% CO2 for
24 h. This experiment was performed in triplicate. Total RNA of
goat PBMCs was extracted using the Ribo-Zero Kit (Ambion,
Austin, Tex, USA) following the manufacturer’s protocol. RNA
integrity was evaluated using the Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). Samples with a
RNA Integrity Number (RIN) ≥ 7 were included in the analysis.
The sequencing libraries were constructed using TruSeq
Stranded Total RNA with Ribo-Zero Globin, according to theApril 2021 | Volume 12 | Article 653755
Wang et al. F. gigantica ESPs and PBMCs Gene Expressionmanufacturer’s instructions. These libraries were sequenced on
an Illumina sequencing platform (HiSeq 2500).
Data Processing and Differential
Expression Analysis
Raw reads generated from high-throughput sequencing were
fastq format sequences. In order to obtain high-quality reads,
trimmomatic software was used to remove low-quality bases, N-
bases, and low-quality reads (20). HISTA2 was used to align
clean reads to the goat reference genome (21). Also, Q20, Q30,
and GC-content of the raw data were calculated (22). The
“estimateSizeFactors” function of the DESeq R package was
used to normalize the read counts (23), and the “nbinomTest”
function was used to calculate P values and fold change values.
The transcript with P-values < 0.05 and |log2 Fold change| > 1
was deemed to be a differentially expressed (DE) transcript.
miRNA Prediction
The small RNA tags were mapped to a reference sequence by
Bowtie (24) to analyze their expression and distribution on the
reference genome. The data of miRBase20.0 were used as miRNA
reference, and modified software miRDeep2 (25) was used to
identify the known miRNAs. The software miREvo (26) and
miRDeep2 (25) were combined to predict novel miRNA by
exploring the secondary structure, the Dicer cleavage site and
the minimum free energy of the small RNA tags unannotated in
the former steps.
CircRNA Prediction
In order to generate a SAM file, BWA software was used to align
the sequencing reads of each sample to the reference genome
(27). Then, the CIRI software was used to scan paired chiastic
clipping (PCC) signals, and circRNA sequences were predicted
based on junction reads and GT-AG cleavage signals (28).
lncRNA Prediction
Stringtie software was used to assemble the known and new
transcripts (29). The candidate lncRNA transcripts wereFrontiers in Immunology | www.frontiersin.org 3screened by comparing with the gene annotation information
of the reference sequence produced by Cuffcompare software
(30). The transcripts with coding potential were then screened
out using CPC (31), CNCI, Pfam (32), and PLEK (27) in order to
obtain lncRNA predicted sequences.
GO and KEGG Enrichment Analysis
Gene Ontology (GO) enrichment was used for functional
annotation analysis. GOseq based Wallenius non-central
hyper-geometric distribution (33), which adjusts for gene
length bias, was implemented for GO enrichment analysis. The
Kyoto Encyclopedia of Genes and Genomes (KEGG) (34)
database (http://www.genome.jp/kegg/) was utilized to test the
statistical enrichment of the target genes in KEGG pathways
using KOBAS software (35).
Quantitative Real-Time PCR (qRT-PCR)
qRT-PCR was performed to validate the transcriptome data
using the SYBR assay according to the manufacturer’s
instructions. The qRT-PCR reactions were carried out using
TB Green® Premix Ex Taq™ II (Tli RNaseH Plus) (Takara,
Shuzo, Kyoto, Japan) with the following reaction conditions:
95°C for 30 s, followed by 40 cycles at 95°C for 5 s and 60°C for
30 s. The GADPH gene was used for mRNA, circRNA, and
lncRNA normalization, while the U6 gene was used for
miRNA’s normalization. Three independent replicates were
examined for each gene and the relative expression of the
target mRNAs, mircRNAs, circRNAs, and lncRNAs was
calculated using the 2−DDCT method. All primers used in this
study are listed in Table 1.
Cell Proliferation Assay by CCK-8 Kit
The effect of F. gigantica ESPs on goat PBMC’s proliferation was
investigated using the CCK-8 kit (Beyotime, Haimen, Jiangsu,
China) as previously described (13). Briefly, goat PBMCs were
incubated with F. gigantica ESPs at concentrations of 5, 10, 20,
40, and 80 µg/ml. Forty-eight hours later, 10 µl of CCK-8 reagent
were added to each cell culture and incubated for 4 h. The OD450TABLE 1 | qRT-PCR primers used in this study.














ENSCHIT00000002081 AGACTGTGTCCAGAGGTAACTA GCTGTGAAAGATGGTGAGTAAATGApr*The GADPH gene was used for mRNA, circRNA and lncRNA normalization, while the U6 gene was used for miRNA’s normalization.il 2021 | Volume 12 | Article 653755
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California, USA).
Statistical Analysis
Student’s t-test was used to analyze the data from qRT-PCR
experiments using GraphPad Prism 5 software (GraphPadFrontiers in Immunology | www.frontiersin.org 4Software, Inc., San Diego, CA, USA). All data are presented as
means ± standard deviations (SDs).RESULTS
ESPs of F. gigantica Promoted the
Proliferation of PBMCs
F. gigantica ESPs promoted the proliferation of goat PBMCs in a
concentration-dependent manner (Figure 1). Significant
differences were detected between cells treated with 20
(p < 0.1), 40 (p < 0.0001) and 80 (p < 0.0001) µg/ml ESPs,
when compared with untreated (control) cells. However, no
significant differences were detected between cells exposed to
lower concentrations (5 or 10 µg/ml) and control cells.
DE mRNAs, miRNAs, circRNAs,
and lncRNAs
The volcano plots (Figure 2) and heat maps (Figure 3) clearly
showed the number and hierarchical clustering of differentiated
mRNAs (Figures 2A and 3A), miRNAs (Figures 2B and 3B),
circRNAs (Figures 2C and 3C), and lncRNAs (Figures 2D and
3D) in ESP-treated and control (untreated) groups. Our
analysis identified 1,544 differently expressed mRNAs
(including 790 upregulated and 754 downregulated, Figure
2A and Supplementary Table S1), 30 differently expressed
miRNAs (including 24 upregulated and 6 downregulated,
Figure 2B and Supplementary Table S2), 136 differently
expressed circRNAs (including 83 upregulated and 53
downregulated, Figure 2C and Supplementary Table S3),
and 1,194 differently expressed lncRNAs (includingFIGURE 1 | The ESPs of F. gigantica promote goat PBMC’s proliferation in a
dose-dependent manner. PBMCs were treated with F. gigantica ESPs at the
indicated range of concentrations for 48 h. Cell proliferation was quantified as
described in the methods (n = 3). The error bars represent standard
deviations. ** p < 0.01; **** p < 0.0001 compared to control
untreated PBMCs.A B
DC
FIGURE 2 | Volcano plots showing the differentially expressed mRNAs (A), miRNAs (B), circRNAs (C), and lncRNAs (D) detected in goat PBMCs after treatment
with F. gigantica ESPs. The negative log10 transformed P values (y-axis) are plotted against the average log2 fold changes in expression (x-axis). Data points
representing RNAs that were not identified as differentially expressed are shown in blue. Transcripts that are differentially expressed after treatment with ESPs
(corrected P value < 0.05) with an absolute log2 fold change (|FC|) greater than or less than 1 are shown as red (upregulated) and green (downregulated) dots.April 2021 | Volume 12 | Article 653755
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Supplementary Table S4).
Validation of DE mRNAs, miRNAs,
circRNAs, and lncRNAs by qRT-PCR
To validate the transcriptome data, a total of 12 genes were
randomly selected for qRT-PCR verification, including three
mRNAs (HDAC1, MCM2, CD47) (Figure 4A), three miRNAs
[16a-3p (chi-miR-16a-3p), 211 (chi-miR-211), 155-3p (chi-miR-
155-3p)] (Figure 4B), three circRNAs (7223 (novel_circ_
0017223), 7701 (novel_circ_0007701), 3459 (novel_circ_
0003459) (Figure 4C), and three lncRNAs [5943 (ENSCHITFrontiers in Immunology | www.frontiersin.org 500000005943), 2500 (LNC_012500), 2081 (ENSCHIT000
00002081)] (Figure 4D). The qRT-PCR analysis showed that
the trend of the data of qRT-PCR expression analysis was
consistent with that of the data obtained by transcriptome
analysis, supporting the accuracy of the transcriptomic data.
GO and KEGG Analysis of the DE mRNAs
To categorize and annotate the biological functions of the DE
transcripts, GO enrichment analysis was performed. The GO
terms were classed into three categories including biological
process, cellular component and molecular function. The top
30 GO terms are shown in Figure 5. The DE mRNAs wereApril 2021 | Volume 12 | Article 653755A B
DC
FIGURE 3 | Hierarchical clustering heatmaps of the differentially expressed genes mRNAs (A), miRNAs (B), circRNAs (C), and lncRNAs (D). Each column
represents the value for one separate experiment of the control and ESP-treated goat PBMCs. Each raw represents the individual RNAs. The colors represent
the level of expression of the RNAs in the sample with red and blue denoting higher and lower expression levels, respectively.
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intracellular organelle part, nucleus and nuclear part
(Figure 5A). Among these, the upregulated mRNAs were also
significantly enriched in cellular component including the
intracellular, intracellular part and organelles (Supplementary
Figure S1A), and the downregulated mRNAs were significantly
enriched in biological processes, such as the immune system
process, regulation of localization, and regulation of the immune
system process (Supplementary Figure S1B). The KEGG
pathway enrichment was used to identify the significantly
enriched pathways of the DE mRNAs. The top 20 pathways
are shown in Figure 5B. Systemic lupus erythematosus,
alcoholism, DNA replication and cell cycle were the most
enriched pathways. Among them, the upregulated mRNAs
were also significantly enriched in Systemic lupus
erythematosus, alcoholism, DNA replication and cell cycle
(Supplementary Figure S1C). The downregulated mRNAs
were significantly enriched in Staphylococcus aureus infection,
lysosome, complement and coagulation cascades, and
phagosome (Supplementary Figure S1D).
GO and KEGG Analysis of the Target
Genes of miRNAs
GO and KEGG pathway analysis was used to probe the main
functions and the involved pathways of the DE miRNAs. As
shown in Figure 6, the DE miRNAs were significantly enriched
in biological processes, such as cell differentiation, cellular
developmental process, and regulation of nervous systemFrontiers in Immunology | www.frontiersin.org 6development. The most enriched pathway of the DE miRNA
was the TGF-beta signaling pathway.
GO and KEGG Analysis of the Target
Genes of circRNAs
The DE circRNAs were significantly enriched in biological
processes, such as positive regulation of cellular process,
positive regulation of biological process, and regulation of
cellular metabolic process (Figure 7A). The most enriched
pathways of the DE circRNAs involved included lysine
degradation, the TNF signaling pathway, the B cell receptor
signaling pathway, and hepatitis C (Figure 7B).
GO and KEGG Analysis of the Target
Genes of lncRNAs
The biological functions of the DE lncRNAs were mainly
involved in biological processes, such as negative regulation of
biological process, organelle organization and macromolecular
complex subunit organization (Figure 8A). Among them, the
upregulated lncRNAs were also significantly enriched in
biological process and cellular component, such as
macromolecular complex subunit organization, chromosome
and chromosome organization (Supplementary Figure S2A).
The downregulated lncRNAs were significantly enriched in the
categories biological process and molecular function, such as
enzyme binding, kinase binding and single-organism cellular
localization (Supplementary Figure S2B). The DE lncRNAs
were significantly enriched in Type I diabetes mellitus,A B
DC
FIGURE 4 | Validation of the expression of representative differentially expressed mRNAs (HDAC1, MCM2, CD47) (A), miRNAs [16a-3p (chi-miR-16a-3p), 211
(chi-miR-211), 155-3p (chi-miR-155-3p)] (B), circRNAs [7223 (novel_circ_0017223), 7701 (novel_circ_0007701), 3459 (novel_circ_0003459)] (C), and lncRNAs
[5943 (ENSCHIT00000005943), 2500 (LNC_012500), 2081 (ENSCHIT00000002081)] (D) using qRT-PCR. The x-axis shows the names of the selected RNAs and
the y-axis shows the relative expression levels. The GADPH gene was used for mRNA, circRNAs, and lncRNA normalization, while the U6 gene was used for
miRNA’s normalization.April 2021 | Volume 12 | Article 653755
Wang et al. F. gigantica ESPs and PBMCs Gene ExpressionInfluenza A and Allograft rejection (Figure 8B). Among them,
the upregulated DE lncRNA were also significantly enriched in
Influenza A, Type I diabetes mellitus and Graft-versus-host
disease (Supplementary Figure S2C). The downregulated DE
lncRNAs were significantly enriched in measles, rheumatoid
arthritis, influenza A, and the chemokine signaling pathway
(Supplementary Figure S2D).Frontiers in Immunology | www.frontiersin.org 7DISCUSSION
In this study, we performed global RNA-seq to profile the
expression of mRNAs, miRNAs, lncRNAs, and circRNAs in
goat PBMCs exposed to F. gigantica ESPs. GO and KEGG
enrichment analysis revealed that F. gigantica ESPs can
influence the expression of transcripts associated with the hostA
B
FIGURE 5 | GO enrichment and KEGG pathway analyses of the differentially expressed mRNAs in goat PBMCs. (A) The 30 most enriched GO terms in the
biological process, cellular component, and molecular function categories. (B) Scatterplot of KEGG pathway analysis of the top 20 pathways. The x-axis represents
the pathway enrichment. The y-axis denotes the names of the significantly enriched pathways. The P-values are indicated by variations from blue to red. A deeper
blue color indicates a greater significant difference.April 2021 | Volume 12 | Article 653755
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and metabolism. In previous studies, we have shown that the F.
gigantica proteins, rFgRab10, rFgCatB and rFg14-3-34, influence
cell proliferation and induce apoptosis in goat PBMCs (11–13).
In the present study, we found that ESPs of F. gigantica promote
cell proliferation as revealed by the CCK-8 assay (Figure 1) and
upregulate cell proliferation-related genes (Table 2) of goat
PBMCs. A previous study revealed that miR-211 suppresses
epithelial ovarian cancer proliferation and cell-cycle
progression by targeting Cyclin D1 and CDK6 (36), and miR-
204-5p suppresses proliferation and invasion, and promotes
chemotherapeutic sensitivity of colorectal cancer cells by
downregulating RAB22A (37). The reduction in the expression
of miR-211 and miR-204-5p in the present study implies a
possible involvement of F. gigantica ESPs in promoting the
proliferation of PBMCs.
TLR3 and TLR4 play a critical role in innate immunity and
induction of inflammatory response (38). Previous studies have
shown that parasite infections, such as F. hepatica, F. gigantica,
Leishmania, and Trypanosoma (39–42), can modulate the
expression of TLRs in order to evade the host’s innate immune
response. For example, stimulation of human monocyte-derived
DCs with live Brugia malayi microfilariae significantly
downregulates mRNA expression of TLR3, TLR4, TLR5 and
TLR7 (43). In cattle, F. hepatica ESP decreases TLR2/TLR4-
mediated immune activation in order to limit excessive
inflammation and attenuate the pathological reactions that
accompany F. hepatica infection (44). Another study suggested
that TLR4 is involved in F. hepatica fatty acid-binding proteinFrontiers in Immunology | www.frontiersin.org 8(FhFABP) and induces alternative activation of human
macrophages (45). FhFABP was suggested to suppress TLR4
activation in macrophages and inhibit the inflammatory
cytokines induced following incubation with LPS (16). In the
present study, PBMCs incubated with F. gigantica ESPs
significantly downregulated mRNA expression of TLR3 and
TLR4 (Table 2). TLR3 suppression promotes a Th2 immune
response to Schistosoma mansoni infection. In S. mansoni
infected TLR3 gene-deficient mice, Th1-associated cytokines
(e.g., IL-12) are significantly decreased and Th2-associated
cytokines and chemokines are significantly increased (46).
rFgCatB protein (component of F. gigantica ESPs) can induce
the expression of Th2-associated cytokines (e.g., IL-4, IL-10, and
TGF-b) (13). These data suggest that reduced expression of
TLR3 skewed the host immune response towards a Th2
response during F. gigantica infection.
Interferon regulatory factor 3 (IRF3) is an important
transcription factor involved in the downstream regulation of
My88-independent TRIF-dependent TLR signaling (46), which
regulates the production of type I IFNs and the induction of
inducible nitric oxide synthase (iNOS) expression (47, 48). iNOS
catalyzes the conversion of arginine into citrulline and nitric
oxide (NO), which protect the host against pathogen invasion
(49). In this study, the expression of IRF3 was significantly
decreased in PBMCs treated with F. gigantica ESPs. The
reduced expression of IRF3 supports the link between
inhibition of TRIF-dependent TLR3 signaling and decreased
expression of NOS2 during F. hepatica infection (50, 51),
which may be one mechanism employed by the liver fluke toFIGURE 6 | GO enrichment of the differentially expressed miRNAs in goat PBMCs. The 30 most enriched GO terms in the biological process, cellular component
and molecular function categories. The y-axis represents the significantly enriched GO terms and the x-axis shows the number of genes in each GO term.April 2021 | Volume 12 | Article 653755
Wang et al. F. gigantica ESPs and PBMCs Gene Expressionavoid damage caused by host-generated NO. These findings
suggest a possible mechanism for F. gigantica ESPs in
suppressing TLR expression or its signaling cascade.
In this study, the expression of miR-148a-5p was upregulated.
miR-148a can inhibit pro-inflammatory cytokines (52). Also,
miR-148a-3p, together with miR-30a-5p, can repress pro-
inflammatory NF-kB signaling and attenuate inflammation (53).Frontiers in Immunology | www.frontiersin.org 9Notably, in the present study, the NF-kB signaling pathway was
suppressed. Therefore, the upregulation of miR-148a-5p detected
in our study may suggest a role for F. gigantica ESPs in shifting
Th1/Th2 towards the Th2 immune response.
Apoptosis of immune cells is an immunosuppressive strategy
employed by F. hepatica, wherein the ESPs induce apoptosis in
eosinophils via a caspase-dependent mechanism, resulting ROS-A
B
FIGURE 7 | GO enrichment and KEGG pathway analyses of target genes of the differentially expressed circRNAs in goat PBMCs. (A) The 30 most enriched GO
terms in the biological process, cellular component and molecular function categories of target genes of differentially expressed circRNAs. (B) Scatterplot of KEGG
pathway analysis of the top 20 predominant pathways. The x-axis denotes the pathway enrichment. The y-axis represents the names of the significantly enriched
pathways. The P-values are indicated by variations from blue to red. A deeper blue color indicates a greater significant difference.April 2021 | Volume 12 | Article 653755
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F. gigantica infection can induce apoptosis in sheep PMBCs
via two distinct pathways: the extrinsic death receptor pathway,
which is induced by the upregulation of TNF and TNFR1/
TNFR2 (40, 50), and the intrinsic mitochondrial pathway (55).
In our study, most death receptors and FAS receptor wereFrontiers in Immunology | www.frontiersin.org 10downregulated, whereas the p53 signaling pathway-related
genes were upregulated (Table 2), suggesting that F. gigantica
ESPs may induce apoptosis through the p53 signaling pathway,
rather than by the Fas/Fasl model. Further investigation of the
role of p53 signaling pathway in F. gigantica–induced apoptosis
of immune cells is warranted.A
B
FIGURE 8 | GO enrichment and KEGG pathway analyses of target genes of the differentially expressed lncRNAs in goat PBMCs. (A) The 30 most enriched GO
terms in the biological process, cellular component and molecular function categories of target genes of differentially expressed lncRNAs. (B) Scatterplot of KEGG
pathway analysis of the top 20 predominant pathways. The x-axis refers to pathway enrichment. The y-axis represents the names of the significantly enriched
pathways. The P-values are expressed by variations from blue to red. A deeper blue color indicates a greater significant difference.April 2021 | Volume 12 | Article 653755
Wang et al. F. gigantica ESPs and PBMCs Gene ExpressionFasciola infection can disrupt liver functions, resulting in
disruption of the overall metabolism of infected livestock and
losses in productivity (56). KEGG analysis revealed that exposure
of goat PBMCs to F. gigantica ESPs upregulated genes related to
lipid, nucleotide, amino acid, carbohydrate, and glycan
metabolism. Alterations in metabolism during infection with F.
gigantica and F. hepatica have been reported in previous studies
(57–59). However, the mechanisms by which F. gigantica ESPs
alter the host metabolic pathways remain to be elucidated.
Noncoding RNAs (miRNAs, circRNAs, and lncRNAs)
participate in the regulation of different biological processes. In
this study, a large number of circRNAs and lncRNAs were
identified. However, the exact functions of these ncRNAs remain
unclear. Pathways analysis indicated that the target genes of
lncRNAs were highly enriched in disease-related pathways, such
as toxoplasmosis, influenza A, and hepatitis B, and immune-related
pathways, such as antigen processing and presentation, the Jak-
STAT signaling pathway, and cytokine-cytokine receptor
interaction. The target genes of circRNAs were highly enriched
in the TNF signaling pathway and Hepatitis C. However, the target
genes of miRNAs were only enriched in the TGF-beta signaling
pathway. The immune-regulatory roles of these ncRNAs during F.
gigantica infection need to be further investigated.
In conclusion, RNA-seq profiling of goat PBMCs treated with
F. gigantica ESPs revealed significant changes in the expression
of mRNAs, miRNAs, lncRNAs and circRNAs. The
abovementioned F. gigantica ESP-induced changes appear to
mediate a number of immune-regulatory mechanisms thatFrontiers in Immunology | www.frontiersin.org 11enable F. gigantica to establish a persistent infection. These
data should form the basis for further in-depth investigations
of ESP-mediated immune-evasion strategies used by F. gigantica
to subvert host immune responses.DATA AVAILABILITY STATEMENT
The datasets presented in this study can be found in online
repositories. The data is deposited in the NCBI repository,
accession number is PRJNA686179.ETHICS STATEMENT
This study was reviewed and approved by the Animal Ethics
Committee of Lanzhou Veterinary Research Institute, Chinese
Academy of Agricultural Sciences (permit no. 2018-012).AUTHOR CONTRIBUTIONS
X-QZ, DC, S-SW, and HE conceived and designed the
experiments. S-SW and DC performed the experiments. J-JH,
W-BZ, A-LT, and G-HZ contributed reagents/materials/analysis
tools. S-SW and DC analyzed the data and wrote the paper. HE,
J-JH, W-BZ, and X-QZ critically revised the manuscript. All
authors read and approved the final version of the manuscript.TABLE 2 | The relative expression of the differentially expressed genes in the corresponding key pathways.
Pathway name Symbol Description Log2 (fold change) P value
Cell Cycle CDK2 Cyclin dependent kinase 2 1.264 0.0085
CDC6 Cell division cycle 6 1.263 0.0151
ORC6 Origin recognition complex subunit 6 1.314 0.0360
ORC1 Origin recognition complex subunit 1 1.587 0.0455
CDC25A Cell division cycle 25A 1.887 0.0256
CDC45 Cell division cycle 45 1.427 0.0185
CHEK1 Checkpoint kinase 1 0.875 0.0296
CHEK2 Checkpoint kinase 2 0.810 0.0033
CCNA2 Cyclin A2 1.122 0.0026
CCNB2 Cyclin B2 1.222 0.0086
MCM2 Minichromosome maintenance complex component 2 1.402 0.0127
BUB1B BUB1 mitotic checkpoint serine/threonine kinase B 0.828 0.0001
MCM7 Minichromosome maintenance complex component 7 1.144 0.0255
CCNE1 Cyclin E1 1.228 0.0015
ESPL1 Extra spindle pole bodies like 1, separase 1.612 0.0150
Toll-like receptor signaling pathway IL12B Interleukin 12B 2.791 0.0026
TLR4 Toll like receptor 4 −1.478 0.0401
TLR3 Toll like receptor 3 −1.737 0.0108
IRF3 Interferon regulatory factor 3 −0.806 0.0470
AKT1 AKT serine/threonine kinase 1 −0.805 0.0038
p53 signaling pathway CCNB2 Cyclin B2 1.222 0.0086
STRAP Serine/threonine kinase receptor associated protein 0.248 0.0210
CDK1 Cyclin dependent kinase 1 0.849 0.0056
CHEK1 Checkpoint kinase 1 0.875 0.0296
CHEK2 Checkpoint kinase 2 0.810 0.0033
CCNE1 Cyclin E1 1.228 0.0015
GADD45A Growth arrest and DNA damage inducible alpha 1.675 0.0325
GADD45B Growth arrest and DNA damage inducible beta 0.745 0.0425
CDK2 Cyclin dependent kinase 2 1.264 0.0085April 2021 | Volume 12 | Article 653755
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pathways. The P-values are indicated by variations from blue to red. A deeper blue
color indicates a greater significant difference.
Supplementary Figure 2 | GO enrichment and KEGG pathway analyses of
target genes of differentially expressed lncRNAs in goat PBMCs. The 30 most
enriched GO terms of the target genes of upregulated (A) and downregulated
(B) lncRNAs in the biological process, cellular component and molecular
function categories. Scatterplots of KEGG pathway analysis of the top 20
predominant pathways of the target genes of upregulated (C) and
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